title: Cholinergic neuromodulation controls directed temporal communication in neocortex in vitro.
abstract: Acetylcholine is the primary neuromodulator involved in cortical arousal in mammals. Cholinergic modulation is involved in conscious awareness, memory formation and attention - processes that involve intercommunication between different cortical regions. Such communication is achieved in part through temporal structuring of neuronal activity by population rhythms, particularly in the beta and gamma frequency ranges (12-80 Hz). Here we demonstrate, using in vitro and in silico models, that spectrally identical patterns of beta2 and gamma rhythms are generated in primary sensory areas and polymodal association areas by fundamentally different local circuit mechanisms: Glutamatergic excitation induced beta2 frequency population rhythms only in layer 5 association cortex whereas cholinergic neuromodulation induced this rhythm only in layer 5 primary sensory cortex. This region-specific sensitivity of local circuits to cholinergic modulation allowed for control of the extent of cortical temporal interactions. Furthermore, the contrasting mechanisms underlying these beta2 rhythms produced a high degree of directionality, favouring an influence of association cortex over primary auditory cortex.
authors.affiliation: Institute of Neuroscience, The Medical School, Newcastle University Newcastle, UK.
authors.forename: Anita K
authors.initials: AK
authors.lastname: Roopun
authors.forename: Fiona E N
authors.initials: FE
authors.lastname: Lebeau
authors.forename: James
authors.initials: J
authors.lastname: Rammell
authors.forename: Mark O
authors.initials: MO
authors.lastname: Cunningham
authors.forename: Roger D
authors.initials: RD
authors.lastname: Traub
authors.forename: Miles A
authors.initials: MA
authors.lastname: Whittington
references.citation: J Neurophysiol. 2003 Nov;90(5):2987-3000
references.pmid: 12815025
references.citation: Conscious Cogn. 2007 Jun;16(2):221-8
references.pmid: 16891124
references.citation: Nat Neurosci. 2000 Sep;3(9):904-10
references.pmid: 10966621
references.citation: Proc Natl Acad Sci U S A. 1985 Sep;82(18):6344-8
references.pmid: 3862134
references.citation: Prog Brain Res. 2004;145:179-96
references.pmid: 14650916
references.citation: Nature. 1996 Oct 17;383(6601):621-4
references.pmid: 8857537
references.citation: Brain Res Brain Res Rev. 1997 Feb;23(1-2):28-46
references.pmid: 9063585
references.citation: J Neurophysiol. 2005 Apr;93(4):2194-232
references.pmid: 15525801
references.citation: Science. 1971 May 7;172(3983):601-2
references.pmid: 4324472
references.citation: Nature. 1999 Nov 4;402(6757):75-9
references.pmid: 10573419
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):346-51
references.pmid: 7845471
references.citation: J Neurobiol. 2002 Dec;53(4):633-40
references.pmid: 12436426
references.citation: J Comp Neurol. 2005 Dec 5;493(1):140-6
references.pmid: 16254988
references.citation: Front Cell Neurosci. 2008 Apr 08;2:1
references.pmid: 18946516
references.citation: Ann N Y Acad Sci. 1995 May 10;757:169-79
references.pmid: 7611672
references.citation: Proc Natl Acad Sci U S A. 2004 May 4;101(18):7152-7
references.pmid: 15103017
references.citation: Trends Cogn Sci. 2005 Oct;9(10):474-80
references.pmid: 16150631
references.citation: Curr Opin Neurobiol. 2007 Dec;17(6):649-55
references.pmid: 18339546
references.citation: Trends Neurosci. 1999 Jun;22(6):273-80
references.pmid: 10354606
references.citation: Arch Med Res. 2007 Jan;38(1):52-5
references.pmid: 17174723
references.citation: Metabolism. 2006 Oct;55(10 Suppl 2):S13-9
references.pmid: 16979420
references.citation: Nature. 1993 Jul 1;364(6432):59-60
references.pmid: 8316297
references.citation: Exp Brain Res. 1991;86(3):483-505
references.pmid: 1722171
references.citation: Cereb Cortex. 1999 Mar;9(2):137-50
references.pmid: 10220226
references.citation: Neural Netw. 2008 Oct;21(8):1094-104
references.pmid: 18599267
references.citation: J Neurosci. 1998 Jun 1;18(11):4244-54
references.pmid: 9592102
references.citation: Nature. 1997 Jan 9;385(6612):157-61
references.pmid: 8990118
references.citation: Br J Pharmacol. 2008 Jul;154(5):1104-15
references.pmid: 18454168
references.citation: Science. 1998 Aug 14;281(5379):985-8
references.pmid: 9703513
references.citation: Science. 2007 Jun 15;316(5831):1609-12
references.pmid: 17569862
references.citation: Neurosci Res. 2000 Sep;38(1):19-26
references.pmid: 10997574
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15646-50
references.pmid: 17030821
references.citation: Neuron. 2007 Mar 1;53(5):735-46
references.pmid: 17329212
references.citation: Exp Brain Res. 1992;89(3):611-22
references.pmid: 1644125
references.citation: Annu Rev Neurosci. 1995;18:555-86
references.pmid: 7605074
references.citation: J Physiol. 2004 Jul 15;558(Pt 2):465-78
references.pmid: 15146046
references.citation: Brain Res. 1995 Dec 18;704(2):167-74
references.pmid: 8788911
references.citation: J Neurophysiol. 2007 Jul;98(1):345-59
references.pmid: 17493916
references.citation: Neuropsychopharmacology. 2001 Sep;25(3):313-9
references.pmid: 11522460
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1867-72
references.pmid: 10677548
references.citation: Science. 2005 Sep 30;309(5744):2228-32
references.pmid: 16195466
references.citation: Neuron. 1997 Sep;19(3):679-86
references.pmid: 9331357
references.citation: J Neurosci. 2004 Nov 17;24(46):10369-78
references.pmid: 15548651